Saturn V Capital Management LP Diversified Active

CIK: 0001964437 · Show all filings

Period: Q4 2022 (Next →)

Filing Date: Feb 9, 2023

Total Value ($000): $120,515 (100.0% shares, 0.0% debt)

Holdings (19)

CRNX CRINETICS PHARMACEUTICALS IN 9.4%
Value ($000) $11,337 Shares 623,819 Est. Cost $17.62 Unrealized 0.0%
2SEVENTY BIO INC 8.2%
Value ($000) $9,886 Shares 684,996 Est. Cost $14.43 Unrealized
APLS APELLIS PHARMACEUTICALS INC 7.8%
Value ($000) $9,414 Shares 212,329 Est. Cost $53.04 Unrealized 0.0%
ARQT ARCUTIS BIOTHERAPEUTICS INC 7.3%
Value ($000) $8,787 Shares 487,179 Est. Cost $17.47 Unrealized 0.0%
CYTK CYTOKINETICS INC 6.6%
Value ($000) $7,974 Shares 196,982 Est. Cost $42.95 Unrealized 0.0%
ASND ASCENDIS PHARMA A/S 6.6%
Value ($000) $7,954 Shares 68,404 Est. Cost $116.28 Unrealized
MORPHIC HLDG INC 6.1%
Value ($000) $7,373 Shares 269,827 Est. Cost $27.33 Unrealized
ITEOS THERAPEUTICS INC 5.8%
Value ($000) $7,028 Shares 342,071 Est. Cost $20.55 Unrealized
ALBIREO PHARMA INC 5.7%
Value ($000) $6,865 Shares 341,827 Est. Cost $20.08 Unrealized
CHINOOK THERAPEUTICS INC 5.6%
Value ($000) $6,728 Shares 423,177 Est. Cost $15.90 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 5.6%
Value ($000) $6,697 Shares 719,937 Est. Cost $5.36 Unrealized 0.0%
CYMABAY THERAPEUTICS INC 4.7%
Value ($000) $5,718 Shares 1,611,778 Est. Cost $3.55 Unrealized
HORIZON THERAPEUTICS PLC 4.7%
Value ($000) $5,681 Shares 69,170 Est. Cost $82.13 Unrealized
SAGE THERAPEUTICS INC 4.5%
Value ($000) $5,368 Shares 156,085 Est. Cost $34.39 Unrealized
FOLD AMICUS THERAPEUTICS INC 4.1%
Value ($000) $4,893 Shares 566,179 Est. Cost $11.26 Unrealized 0.0%
BCRX BIOCRYST PHARMACEUTICALS INC 3.1%
Value ($000) $3,751 Shares 340,163 Est. Cost $12.47 Unrealized 0.0%
BIIB BIOGEN INC 1.8%
Value ($000) $2,170 Shares 7,660 Est. Cost $282.44 Unrealized 0.0%
ASTRIA THERAPEUTICS INC 1.3%
Value ($000) $1,557 Shares 169,493 Est. Cost $9.18 Unrealized
TBPH THERAVANCE BIOPHARMA INC 1.1%
Value ($000) $1,334 Shares 141,339 Est. Cost $10.51 Unrealized 0.0%